Published in Int J Androl on June 15, 2009
HIV-1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV AIDS (2011) 3.39
Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria. AIDS (2013) 2.17
Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques. Nat Methods (2015) 1.72
Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology (2010) 1.70
Human immunodeficiency virus infects human seminal vesicles in vitro and in vivo. Am J Pathol (2011) 0.94
Role of P-glycoprotein in the distribution of the HIV protease inhibitor atazanavir in the brain and male genital tract. Antimicrob Agents Chemother (2013) 0.91
Genital tract sequestration of SIV following acute infection. PLoS Pathog (2011) 0.90
Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection. Cell Mol Immunol (2014) 0.88
Viral RNA levels and env variants in semen and tissues of mature male rhesus macaques infected with SIV by penile inoculation. PLoS One (2013) 0.85
Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy. J Virol (2015) 0.83
Impact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs. PLoS One (2012) 0.81
The integrated HIV-1 provirus in patient sperm chromosome and its transfer into the early embryo by fertilization. PLoS One (2011) 0.81
Why sexually transmitted infections tend to cause infertility: an evolutionary hypothesis. PLoS Pathog (2014) 0.80
Beyond Mortality: Sterility As a Neglected Component of Parasite Virulence. PLoS Pathog (2015) 0.77
The HIV-1 transmission bottleneck. Retrovirology (2017) 0.75
Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med (2002) 9.70
Sexual transmission of HIV. N Engl J Med (1997) 6.84
Relation between HIV viral load and infectiousness: a model-based analysis. Lancet (2008) 5.74
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A (1999) 5.25
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA (1999) 4.98
Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr (2005) 4.96
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS (2000) 4.91
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS (2001) 4.76
Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Lancet (2005) 4.21
Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA (2002) 4.02
Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med (1998) 3.81
Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol (1996) 3.48
Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med (1998) 3.14
Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis (1998) 2.98
Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS (2009) 2.77
Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. AIDS (2008) 2.27
Is transmission of HIV-1 in non-viraemic serodiscordant couples possible? Antivir Ther (2008) 2.21
Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (2003) 2.03
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos (2000) 1.87
T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis (1997) 1.85
Detection of HIV-related protein in testes and prostates of patients with AIDS. Am J Clin Pathol (1990) 1.72
Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1. Antimicrob Agents Chemother (1999) 1.68
Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen. J Infect Dis (2000) 1.61
Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS (1998) 1.59
Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. J Infect Dis (1991) 1.57
Effects of antiretroviral therapy on semen quality. AIDS (2008) 1.54
CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol (2004) 1.52
Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J Virol (2005) 1.52
Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS (1999) 1.51
Pathology and localization of simian immunodeficiency virus in the reproductive tract of chronically infected male rhesus macaques. Lab Invest (1994) 1.50
Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS (2007) 1.50
Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev (2001) 1.49
The effect of human immunodeficiency virus on sperm parameters and the outcome of intrauterine insemination following sperm washing. Hum Reprod (2004) 1.48
Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men. AIDS (2004) 1.44
Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men. AIDS (1994) 1.43
HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men. AIDS (2009) 1.43
Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men. AIDS (2004) 1.42
Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS (1994) 1.38
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol (2000) 1.38
Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations. HIV Clin Trials (2002) 1.37
The biologic significance of white blood cells in semen. Fertil Steril (1995) 1.35
The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. AIDS (2007) 1.34
Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J Infect Dis (2001) 1.33
Predictive value of primate models for AIDS. AIDS Rev (2005) 1.32
Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis (1999) 1.28
Subcompartmentalization of HIV-1 quasispecies between seminal cells and seminal plasma indicates their origin in distinct genital tissues. AIDS Res Hum Retroviruses (2002) 1.27
Antiretroviral drug concentrations in semen of HIV-1 infected men. Sex Transm Infect (2001) 1.27
Orchitis and human immunodeficiency virus type 1 infected cells in reproductive tissues from men with the acquired immune deficiency syndrome. Am J Pathol (1991) 1.26
Is natural conception a valid option for HIV-serodiscordant couples? Hum Reprod (2007) 1.25
Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. AIDS (2004) 1.22
Effect of antiretroviral therapy on HIV shedding in semen. Ann Intern Med (2000) 1.20
Evaluation of sperm washing as a potential method of reducing HIV transmission in HIV-discordant couples wishing to have children. AIDS (1999) 1.18
Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA. J Infect Dis (1994) 1.18
Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. J Antimicrob Chemother (2001) 1.14
Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir. AIDS Res Hum Retroviruses (1998) 1.14
An evaluation of semen processing methods for eliminating HIV-1. AIDS (2000) 1.13
HIV-1 nucleic acids localize to the spermatogonia and their progeny. A study by polymerase chain reaction in situ hybridization. Am J Pathol (1994) 1.13
Vasectomy and human immunodeficiency virus type 1 in semen. J Urol (1998) 1.13
Infection of semen-producing organs by SIV during the acute and chronic stages of the disease. PLoS One (2008) 1.07
Human immunodeficiency virus type 1--serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril (1998) 1.06
Semen analysis in human immunodeficiency virus infection. Fertil Steril (1992) 1.03
Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012). AIDS (2002) 1.02
HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands. Mol Membr Biol (1999) 1.00
Interaction of human immunodeficiency virus with human sperm in vitro. J Acquir Immune Defic Syndr (1988) 1.00
Susceptibility of human testis to human immunodeficiency virus-1 infection in situ and in vitro. Am J Pathol (2006) 0.98
Human testis in organotypic culture: application for basic or clinical research. Hum Reprod (2006) 0.97
The prostate as a reservoir for HIV-1. AIDS (2004) 0.96
HIV-particles in spermatozoa of patients with AIDS and their transfer into the oocyte. J Cell Biol (1994) 0.95
CD4 independent binding of HIV gp120 to mannose receptor on human spermatozoa. J Acquir Immune Defic Syndr (2008) 0.95
Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine. J Antimicrob Chemother (2008) 0.95
Semen analysis in HIV seropositive men and in subjects at high risk for HIV infection. Hum Reprod (1996) 0.95
HIV-1 in semen: an isolated virus reservoir. Lancet (1997) 0.95
Spermatozoon as a vehicle for HIV-1 and other viruses: a review. Mol Reprod Dev (2000) 0.93
Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr (1992) 0.93
Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS (2000) 0.92
Semen characteristics in human immunodeficiency virus (HIV)- and hepatitis C (HCV)-seropositive males: predictors of the success of viral removal after sperm washing. Hum Reprod (2004) 0.92
White blood cells and HIV-1 in semen from vasectomised seropositive men. Lancet (1991) 0.91
Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo. Retrovirology (2008) 0.91
The testis and epididymis are productively infected by SIV and SHIV in juvenile macaques during the post-acute stage of infection. Retrovirology (2007) 0.90
Concordance between semen-derived HIV-1 proviral DNA and viral RNA hypervariable region 3 (V3) envelope sequences in cases where semen populations are distinct from those present in blood. J Med Virol (2002) 0.89
The effects of disease progression and zidovudine therapy on semen quality in human immunodeficiency virus type 1 seropositive men. Fertil Steril (1994) 0.89
Effects of clinical stage and immunological status on semen analysis results in human immunodeficiency virus type 1-seropositive men. Andrologia (1998) 0.88
Medically assisted reproduction in the presence of chronic viral diseases. Hum Reprod Update (2004) 0.87
Reverse transcriptase activity in mature spermatozoa of mouse. J Cell Biol (2000) 0.87
Sperm cells and foreign DNA: a controversial relation. Bioessays (1998) 0.87
Complete removal of HIV-1 RNA and proviral DNA from semen by the swim-up method: assisted reproduction technique using spermatozoa free from HIV-1. AIDS (2006) 0.86
Viruses in semen and male genital tissues--consequences for the reproductive system and therapeutic perspectives. Curr Pharm Des (2004) 0.85
Decreased semen volume and spermatozoa motility in HIV-1-infected patients under antiretroviral treatment. J Androl (2007) 0.85
Semen quality remains stable during 96 weeks of untreated human immunodeficiency virus-1 infection. Fertil Steril (2007) 0.84
HIV-1 viral DNA is present in ejaculated abnormal spermatozoa of seropositive subjects. Hum Reprod (2007) 0.83
Human Leydig cells are productively infected by some HIV-2 and SIV strains but not by HIV-1. AIDS (2003) 0.83
Expression of fractalkine in the Fallopian tube and of CX3CR1 in sperm. Hum Reprod (2004) 0.83
Testicular germ cells of HIV-seropositive asymptomatic men are infected by the virus. J Reprod Immunol (1998) 0.83
Multiple drug resistance mutations in human immunodeficiency virus in semen but not blood of a man on antiretroviral therapy. Urology (2000) 0.83
New insights into the interaction between the gp120 and the HIV receptor in human sperm (human.sperm/gp120/galactoglycerolipid/antigalactosylceramide/seminolip id/spermatogonia). J Reprod Immunol (1998) 0.83
Glycolipids as potential binding sites for HIV: topology in the sperm plasma membrane in relation to the regulation of membrane fusion. J Reprod Immunol (1998) 0.83
Semen alterations in HIV-1 infected men. Hum Reprod (2002) 0.82
Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract. AIDS (2008) 0.82
Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections. Antivir Ther (2003) 0.82
Fertility parameters in men infected with human immunodeficiency virus. J Infect Dis (1991) 0.81
Human testis steroidogenesis is inhibited by phthalates. Hum Reprod (2012) 1.10
Paracetamol (acetaminophen), aspirin (acetylsalicylic acid) and indomethacin are anti-androgenic in the rat foetal testis. Int J Androl (2012) 1.06
Human testis in organotypic culture: application for basic or clinical research. Hum Reprod (2006) 0.97
Antiviral responses of human Leydig cells to mumps virus infection or poly I:C stimulation. Hum Reprod (2008) 0.82
[The male genital tract: A host for HIV]. Gynecol Obstet Fertil (2007) 0.81
Experimental inoculation of the adult rat testis with Sendai virus: effect on testicular morphology and leukocyte population. Hum Reprod (2003) 0.78
Paracetamol, aspirin and indomethacin display endocrine disrupting properties in the adult human testis in vitro. Hum Reprod (2013) 0.78